Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03661437 · ClinicalTrials.gov registry record · Early Phase 1

Systemic Light Exposure in Preventing Frailty in Older Patients With Prostate Cancer on Hormonal Therapy

A Early Phase 1 study of Prostate Carcinoma, sponsored by City of Hope Medical Center.

Completed
Registry status
Early Phase 1
Development phase
33
Enrollment target
1
Study location

NCT03661437 is a Early Phase 1 study of Prostate Carcinoma that has completed, run by City of Hope Medical Center. The registered enrollment target is 33 participants, below the 1,501-participant average among 59 other Prostate Carcinoma trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03661437, a Early Phase 1 study of Prostate Carcinoma, has completed, sponsored by City of Hope Medical Center.

COMPLETED
Registry status
Early Phase 1
Development phase
33 participants
Enrollment target
1
Study location

Study Summary

This pilot trial studies how well systemic light exposure works in preventing frailty in older patients with prostate cancer on hormonal therapy. Hormone therapy causes many symptoms of frailty in older men including fatigue, slower time to walk a specified distance, reduced activity levels, loss of lean muscle, and muscle weakness. It is not yet known if systemic light exposure may reduce frailty in older prostate cancer patients.

Conditions Studied

Prostate Carcinoma

Interventions

  • OTHER Questionnaire Administration
  • DEVICE Actigraph
  • PROCEDURE Systematic Light Exposure

Study Locations (1)

California

  • City of Hope Medical Center - Duarte

Trial Details

FieldValue
Enrollment Target 33 participants
Start Date 2018-09-24
Est. Completion 2025-03-24
Phase Early Phase 1

Sponsor

City of Hope Medical Center

582 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03661437

The ClinicalTrials.gov registry entry for NCT03661437 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,501-participant average among 59 other Prostate Carcinoma trials with a reported enrollment target (98% lower). The listed sponsor is City of Hope Medical Center, which has 582 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Prostate Carcinoma appearing as the primary indexed condition, and to 3 interventions - of which Questionnaire Administration is the first listed.

NCT03661437 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT03661437 about?

NCT03661437 is a clinical study titled "Systemic Light Exposure in Preventing Frailty in Older Patients With Prostate Cancer on Hormonal Therapy". This pilot trial studies how well systemic light exposure works in preventing frailty in older patients with prostate cancer on hormonal therapy. Hormone therapy causes many symptoms of frailty in older men including fatigue, slower time to walk a specified distance, reduced activity levels, loss of...

What is the current status of trial NCT03661437?

This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 33 participants. The study started on 2018-09-24. Estimated completion is 2025-03-24.

What conditions does trial NCT03661437 study?

This clinical trial studies the following conditions: Prostate Carcinoma.

What interventions are being tested in trial NCT03661437?

The interventions under investigation include: Questionnaire Administration (OTHER), Actigraph (DEVICE), Systematic Light Exposure (PROCEDURE).

Who is sponsoring clinical trial NCT03661437?

This trial is sponsored by City of Hope Medical Center, which has 582 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03661437 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Prostate Carcinoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Prostate Carcinoma

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.